lamivudin [Lamivudine]

tematický
95
Termíny

2(1H)-pyrimidinon, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)-
3TC lamivudin
BCH-189
Epivir
GR-109714X
GR109714X
lamivudin, (+-)-trans-
lamivudin, (+)-cis-
lamivudin, (2S-cis)-izomer

 

2',3'-Dideoxy-3'-thiacytidine
2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)-
3TC Lamivudine
BCH-189
Epivir
GR-109714X
GR109714X
Lamivudine, (+-)-trans-
Lamivudine, (+)-cis-
Lamivudine, (2S-cis)-Isomer

Perzistentní odkaz   https://www.medvik.cz/link/D019259
Definice

A reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat HIV disease.

DUI
D019259 MeSH Prohlížeč
CUI
M0028682
RN
2T8Q726O95
Předchozí užití
Cytosine/analogs & derivatives (1991-1992); Zalcitabine/analogs & derivatives (1993-1996)
Historická pozn.
97; was LAMIVUDINE (NM) 1991-96
Online pozn.
use LAMIVUDINE (NM) to search LAMIVUDINE 1991-96
Veřejná pozn.
97; LAMIVUDINE was indexed under ZALCITABINE/analogs & derivatives 1993-96 and CYTOSINE/analogs & derivatives 1991-92

D Chemikálie a léčiva
D03.383.742 pyrimidiny 958
D03.383.742.680 pyrimidinové nukleosidy 23
D03.383.742.680.245 cytidin 35
D03.383.742.680.245.500 deoxycytidin 307
D03.383.742.680.245.500.950 dideoxycytidin 8
D03.383.742.680.245.500.950.500 lamivudin 95
D13.570 nukleosidy 265
D13.570.230 deoxyribonukleosidy 14
D13.570.230.329 deoxycytidin 307
D13.570.230.329.950 dideoxycytidin 8
D13.570.230.329.950.500 lamivudin 95
D13.570.230.500 dideoxynukleosidy 19
D13.570.230.500.925 dideoxycytidin 8
D13.570.230.500.925.500 lamivudin 95
D13.570.685.245 cytidin 35
D13.570.685.245.500 deoxycytidin 307
D13.570.685.245.500.950 dideoxycytidin 8
D13.570.685.245.500.950.500 lamivudin 95